Literature DB >> 31116153

Relation of short-term blood pressure variability to early renal effects in hypertensive patients with controlled blood pressure.

Hazem M A Farrag1, Amr S Amin, Alaa-Eddin R Abdel-Rheim.   

Abstract

INTRODUCTION: Microalbuminuria is a common early hypertension-mediated organ damage, which correlates with the overall cardiovascular risk and development of end-stage renal damage. Lately, blood pressure variability has shown an additive value over traditional BP measurement in prediction of cardiovascular and renal involvement. AIM: Investigate the relation between short-term blood pressure variability and microalbuminuria in controlled hypertensive patients. PATIENTS AND METHODS: Ninety non-diabetic hypertensive patients with controlled blood pressure and normal estimated glomerular filtration rate had 24-hour ambulatory blood pressure monitoring with calculation of short-term blood pressure variability indices (SD, coefficient of variation and average reading variability of systolic and diastolic blood pressure for 24-hour, daytime and nighttime], and measurement of the albumin/creatinine ratio.
RESULTS: Patients were classified into group 1 (61 patients without microalbuminuria) and group 2 (29 patients with microalbuminuria). No significant difference was observed between both groups regarding age, sex, body mass index, office blood pressure, average 24-hour ambulatory blood pressure monitoring readings and dipping status, but significantly longer duration of hypertension in group 2. All blood pressure variability indices were significantly higher in group 2, which showed strong positive correlations with microalbuminuria level. Multivariate analysis represented an average reading variability of 24-hour systolic blood pressure as the most powerful independent predictor for microalbuminuria (r = 0.516, P = 0.001). Receiver operating characteristic curve analysis revealed that average reading variability of 24-hour systolic blood pressure (>12.55) could predict microalbuminuria (sensitivity = 89.7%, specificity = 88.5%, area under curve = 0.949, P = 0.001).
CONCLUSION: Short-term blood pressure variability correlated well with early renal effects in controlled hypertensive patients. Average reading variability of 24-hour systolic blood pressure was the strongest predictor for microalbuminuria in such patients.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31116153     DOI: 10.1097/MBP.0000000000000383

Source DB:  PubMed          Journal:  Blood Press Monit        ISSN: 1359-5237            Impact factor:   1.444


  4 in total

Review 1.  Annual reports on hypertension research 2020.

Authors:  Masaki Mogi; Yukihito Higashi; Kanako Bokuda; Atsuhiro Ichihara; Daisuke Nagata; Atsushi Tanaka; Koichi Node; Yoichi Nozato; Koichi Yamamoto; Ken Sugimoto; Hirotaka Shibata; Satoshi Hoshide; Hitoshi Nishizawa; Kazuomi Kario
Journal:  Hypertens Res       Date:  2021-10-15       Impact factor: 3.872

2.  Effects of combined training performed two or four times per week on 24-h blood pressure, glycosylated hemoglobin and other health-related outcomes in aging individuals with hypertension: Rationale and study protocol of a randomized clinical trial.

Authors:  Rodrigo Ferrari; Lucas Betti Domingues; Leandro de Oliveira Carpes; Paula de Azevedo Frank; Vinícius Mallmann Schneider; Sandra C Fuchs
Journal:  PLoS One       Date:  2021-05-26       Impact factor: 3.240

3.  24-h ambulatory blood pressure variability and hypertensive nephropathy in Han Chinese hypertensive patients.

Authors:  Ming-Hui Hung; Chin-Chou Huang; Chia-Min Chung; Jaw-Wen Chen
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-11-21       Impact factor: 3.738

4.  Sex Differences in Post-exercise Hypotension, Ambulatory Blood Pressure Variability, and Endothelial Function After a Power Training Session in Older Adults.

Authors:  Leandro de Oliveira Carpes; Lucas Betti Domingues; Renato Schimitt; Sandra C Fuchs; Taha Alhalimi; Hirofumi Tanaka; Rodrigo Ferrari
Journal:  Front Physiol       Date:  2021-07-16       Impact factor: 4.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.